(Q41892038)

13 October 2017

Difference in tissue expression of tumour markers CA 19-9 and CA 50 in hepatocellular carcinoma and cholangiocarcinoma (English)

1 reference

8 December 2022

0 references

1 reference

8 December 2022

author name string

C. Haglund

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848439

8 December 2022

J. Lindgren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848439

8 December 2022

P. J. Roberts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848439

8 December 2022

S. Nordling

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848439

8 December 2022

language of work or name

English

0 references

publication date

1 March 1991

1 reference

PMCID

1971873

full work available at URL

13 October 2017

https://europepmc.org/articles/PMC1971873

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848439

https://europepmc.org/articles/PMC1971873?pdf=render

8 December 2022

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1848439

http://www.nature.com/articles/bjc199190.pdf

8 December 2022

file format

Portable Document Format

1 reference

http://www.nature.com/articles/bjc199190

8 December 2022

1 reference

British Journal of Cancer

8 December 2022

published in

1 reference

13 October 2017

63

1 reference

13 October 2017

3

1 reference

13 October 2017

386-389

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1991.90

13 October 2017

0 references

cites work

Initial clinical evaluation of an immunoradiometric assay for CA 19-9 using the nci serum bank

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971873

Comparison of a new tumour marker, CA 19-9, with alpha-fetoprotein and carcinoembryonic antigen in patients with upper gastrointestinal diseases

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971873

Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971873

Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971873

Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971873

Comparison of CA-50, a new tumour marker, with carcinoembryonic antigen (CEA) and alpha-fetoprotein (AFP) in patients with gastrointestinal diseases

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971873

Colorectal carcinoma antigens detected by hybridoma antibodies

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971873

Distribution of five antigens in hepatocellular carcinoma

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971873

A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.

5 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971873

Serum CA 50 as a tumor marker in pancreatic cancer: a comparison with CA 19-9

18 August 2018

1 reference

12 December 2020

The use of CA-50 radioimmunoassay inhibition test in the differential diagnosis of benign and malignant liver diseases

1 reference

12 December 2020

Chemical structure of carcinoma ganglioside antigens defined by monoclonal antibody C-50 and some allied gangliosides of human pancreatic adenocarcinoma

1 reference

12 December 2020

Distribution of albumin- and/or alpha-fetoprotein-positive cells in hepatocellular carcinoma

1 reference

12 December 2020

Distribution of monoclonal antibody-defined monosialoganglioside in normal and cancerous human tissues: an immunoperoxidase study

1 reference

12 December 2020

Monoclonal antibodies against gastrointestinal tumour-associated antigens isolated as monosialogangliosides

1 reference

12 December 2020

Gastrointestinal cancer-associated antigen in immunoperoxidase assay

1 reference

12 December 2020

Sialosyllactotetraosylceramide, a novel ganglioside antigen detected in human carcinomas by a monoclonal antibody

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1991.90

1 reference

13 October 2017

1 reference

13 October 2017

1 reference

PMCID

1971873